Scientists from the Faculty of Pharmacy and Biochemistry and the company Genos led a large study involving researchers from England, Scotland, Finland, Australia, and China, and by analyzing glycans linked to plasma proteins in over 1500 individuals with diabetes, they determined that glycan biomarkers can identify individuals at high risk for developing diabetes, it was announced on Friday by Genos.
>>>Diabetes: Vegetable Soups and Teas Help the Pancreas Regenerate Itself
Changes in glycans occur years before the first appearance of disease symptoms, allowing for very early diagnosis and preventive action to delay or even completely avoid the development of diabetes. The results of this research were published in one of the leading international journals in the field of diabetes, “Diabetologia.”
Although it will likely take several years before the application of this biomarker in routine clinical practice, a large project for its clinical validation has been planned as part of the Competence Center project in personalized medicine, which will involve nearly 2000 participants in Croatia, allowing them to be among the first in the world to try this test.
